Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection)...
12 KB (710 words) - 08:51, 21 October 2023
intravenously, particularly for the treatment of resistant Candida species. Ibrexafungerp Acrisorcin Amorolfine – a morpholine derivative used topically in dermatophytosis...
28 KB (2,565 words) - 10:26, 3 June 2024
found to harbor fungi with potent anti-fungal compounds, including ibrexafungerp, which is now FDA approved to treat fungal infections. Farjon, A. (2013)...
18 KB (1,799 words) - 01:40, 6 March 2024
J02AX04 Caspofungin J02AX05 Micafungin J02AX06 Anidulafungin J02AX07 Ibrexafungerp J02AX08 Rezafungin acetate "ATC (Anatomical Therapeutic Chemical Classification...
877 bytes (221 words) - 07:30, 31 December 2022
at least 7 days. All are more or less equally effective. By mouth: ibrexafungerp, fluconazole as a single dose. For severe disease another dose after...
30 KB (2,992 words) - 05:28, 27 May 2024
Krause R, et al. (October 2021). "The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin". Drugs. 81 (15): 1703–1729...
211 KB (21,611 words) - 17:44, 9 June 2024
Krause R, et al. (October 2021). "The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin". Drugs. 81 (15): 1703–1729...
6 KB (380 words) - 18:47, 6 May 2024
for more efficient antifungal therapies, however, as novel drugs like Ibrexafungerp – a glucan synthase inhibitor – is somewhat effective in treating S...
23 KB (2,567 words) - 19:19, 1 March 2024